| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |